![Scott Byrd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Byrd
Presidente presso
ACACIA PHARMA GROUP PLC
Profilo
Scott A. Byrd is Chief Executive Officer & Director at Sudo Biosciences, Inc. since 2021.
Mr. Byrd is Independent Chairman at Acacia Pharma Group Ltd. since 2015.
Mr. Byrd is Non-Executive Director at Acacia Pharma Ltd. Mr. Byrd is Independent Director at AlgoTherapeutix SAS. Formerly, Mr. Byrd was President, CEO, Secretary & Treasurer at Outpost Medicine, Inc. Mr. Byrd was President & Chief Executive Officer at Outpost Medicine Ltd. from 2017 to 2023.
Mr. Byrd was Senior Director-Global Brands at Eli Lilly & Co. from 1992 to 2006.
Mr. Byrd was Chief Commercial Officer & Senior Vice President at Mallinckrodt Hospital Products, Inc. from 2009 to 2014.
Mr. Byrd was President & Chief Operating Officer at Acacia Pharma, Inc. from 2009 to 2014.
Education includes undergraduate degree from Bradley University and MBA from Harvard Business School.
Posizioni attive di Scott Byrd
| Società | Posizione | Inizio |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Presidente | 02/03/2020 |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Direttore/Membro del Consiglio | - |
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Direttore/Membro del Consiglio | - |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Amministratore Delegato | 01/04/2021 |
Precedenti posizioni note di Scott Byrd
| Società | Posizione | Fine |
|---|---|---|
Outpost Medicine Ltd.
 Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | 05/09/2023 |
| CADENCE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 19/03/2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Amministratore Delegato | - |
Acacia Pharma, Inc.
 Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Presidente | 01/01/2014 |
Formazione di Scott Byrd
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
85
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Bradley University
 Bradley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Acacia Pharma, Inc.
Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Health Technology |
Outpost Medicine Ltd.
Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
